Abstract
The important problem of initiation of long-term lithium treatments tackled by means of the selection of an a prioridosage regimen based on the presumed efficacy of lithium and absence of toxicity. The pharmacokinetics of Li + ion is represented by a four-compartment open model including the supposed first-order processes for the release of the active compound from the dosage form and its absorption. Experimental protocols for measurements of serum concentrations and of urinary amounts after single and multiple dosing to healthy volunteers were derived with several oral dosage forms. Estimation of the pharmacokinetic parameters for each subject made it possible to validate the model for the various dosage forms. The interindividual variability of these parameters is taken into account by estimating the characteristics of the statistical distribution for the whole population. A dosage regimen is considered optimum when serum concentration profiles at steady state range from the threshold of efficacy (0.8 mmol/liter) to the threshold of toxicity (2.0 mmol/liter). When the number of daily intakes is fixed, the search for the optimum dose for the whole population is effected by minimizing the expected value of the random variable which characterizes the risks of excursion out of the therapeutic range. By this means universal dosages are shown to be unsatisfactory. However, certain dosage regimens individualized with respect to the renal clearance value of lithium and based on two or three daily intakes can give excellent results even when conventional dosage forms are used.
Similar content being viewed by others
References
J. F. J. Cade. Lithium salts in the treatment of psychotic excitement.Med. J. Aust. 36:349–352 (1949).
M. Schou, N. Juel-Nielsen, E. Strömgren, and H. Voldby. The treatment of manic psychosis by the administration of lithium salts.J. Neurol. Neurosurg. Psychiat. 17:250–260 (1954).
R. J. Greene. Clinical pharmaceutical aspects of lithium therapy.Drug Intell. Clin. Pharmacol. 9:17–25 (1975).
S. Gershon and B. Shopsin.Lithium—Its Role in Psychiatric Research and Treatment, Plenum Press, New York, 1973.
F. N. Johnson.Lithium Research and Therapy, Academic Press, New York, 1975.
A. Frazer, J. Mendels, S. K. Secunda, C. M. Cochrane, and C. P. Bianchi. The prediction of brain lithium concentrations from plasma or erythrocyte measures.J. Psychiat. Res. 10:1–7 (1973).
T. B. Cooper, P. E. E. Bergner, and G. M. Simpson. The 24-hour serum lithium level as a prognosticator of dosage requirements.Am. J. Psychiat. 130:601–603 (1973).
T. B. Cooper and G. M. Simpson. The 24-hour lithium level as a prognosticator of dosage requirements: A 2-year follow-up study.Am. J. Psychiat. 133:440–443 (1976).
A. Amdisen. Monitoring of lithium treatment through determination of lithium concentration.Dan. Med. Bull 22:277–291 (1975).
P. E. E. Bergner, K. Berniker, T. B. Cooper, J. R. Gradijan and G. M. Simpson. Lithium kinetics in man: Effect of variation in dosage pattern.Br. J. Pharmacol. 49:328–339 (1973).
J. L. Crammer, R. M. Rosser, and G. Crane. Blood levels and management of lithium treatment.Br. Med. J. 3:650–654 (1974).
A. Coppen, J. E. Bailey, and S. G. White. Slow-release lithium carbonate.J. Clin. Pharmacol. 9:160–163 (1969).
A. Coppen and J. E. Bailey. Sustained-release lithium carbonate.Int. Pharmacopsychiat. 5:183–186 (1970).
K. Ventouras, P. Dick, and P. Buri. Etude d'une nouvelle forme galénique á action prolongée de sulfate de lithium.Schweiz. Med. Wschr. 103:878–881 (1973).
L. B. Sheiner, B. Rosenberg, and K. L. Melmon. Modelling of individual pharmacokinetics for computer-aided drug dosage.Comp. Biomed. Res. 5:441–459 (1972).
L. B. Sheiner, B. Rosenberg, and V. V. Marathe. Estimation of population characteristics of pharmacokinetic parameters from routine clinical data.J. Pharmacokin. Biopharm. 5:445–479 (1977).
E. Widerlöv. A comparative double-blind study of the side effects of Litarex and Lithionit Duretter.Acta Psychiat. Scand. 54:294–302 (1976).
G. Persson. Plasma lithium levels and side effects during administration of a slow release lithium sulphate preparation (lithium Lipett C) and lithium carbonate tablets.Acta Psychiat. Scand. 50:174–182 (1974).
A. C. Altamura, R. Gomeni, E. Sachetti, and E. Smeraldi. Plasma and intracellular kinetics of lithium after oral administration of various lithium salts.Eur. J. Clin. Pharmacol. 12:59–63 (1977).
H. C. Caldwell. Dissolution of lithium and magnesium from lithium carbonate capsules containing magnesium stearate.J. Pharm. Sci. 63:770–773 (1974).
M. Schou and D. M. Shaw. Lithium in recurrent manic-depressive disorder.Practitioner 210:105–111 (1973).
A Amdisen. Serum level monitoring and clinical pharmacokinetics of lithium.Clin. Pharmacol. 2:73–92 (1977).
J. G. Wagner.Biopharmaceutics and Relevant Pharmacokinetics, Drug Intelligence Publications, Hamilton, Ill. 1971.
H. C. Caldwell, W. J. Westlake, S. M. Connor, and T. Flanagan. A pharmacokinetic analysis of lithium carbonate absorption from several formulations in man.J. Clin. Pharmacol. 11:349–356 (1971).
J. Richalet, A. Fault, and R. Pouliquen.Identification des Processus par la Méthode du Modéle, Gordon and Breach, London, 1973.
D. W. Marquardt. An algorithm for least-squares estimation of non-linear parameters.J. Soc. Indust. Appl. Math. 2:431–441 (1963).
D. Dumas de Rauly.L'Estimation Statistique, Gauthier-Villars, Paris, 1968.
N. R. Draper and H. Smith.Applied Regression Analysis, Wiley, New York, 1966.
G. Prevost. Estimation of a normal probability density function from samples measured with non-negligible and non-constant dispersion. Internal report, June 1977, Adersa-Gerbios, 53 avenue de l'Europe—F. 78140, Velizy-Villacoublay.
Y. Bard.Nonlinear Parameter Estimation, Academic Press, New York, 1974.
J. F. Boisvieux. Modelisation et commande des processus biologiques. Aspects théoriques et mise en oeuvre. Thése d'Etat és Sciences Physiques, Université de Paris VI, 1977.
J. L. Steimer. Optimisation de la posologie d'un médicament. Aspects méthodologiques et application au lithium. Thése de 3éme cycle, Statistique Mathématique, Université de Paris VI, 1978.
M. M. Schou, P. C. Baastrup, P. Graf, P. Weis, and J. Angst. Pharmacological and clinical problems of lithium prophylaxis.Br. J. Psychiat. 116:615–619 (1970).
P. C. Baastrup. Practical problems concerning lithium maintenance therapy. In Vinar, Votova, and Bradly (eds.),Advances in Neuropsychopharrnacology, Vol. 1, North-Holland, Amsterdam, 1971
E. Krüger-Thiemer. Pharmacokinetics and dose-concentration relationships. InPhysico-chemical Aspects of Drug Actions, Pergamon Press, New York, 1968.
J. G. Wagner.Fundamentais of Clinical Pharmacokinetics, Drug Intelligence Publications, Hamilton, Ill., 1975.
R. W. Jelliffe, J. Buell, R. Kalaba, R. Sridhar, and R. Rockwell. A mathematical study of the metabolic conversion of digitoxin to digoxin in man.Math. Biosci. 6:387–403 (1970).
R. W. Jelliffe, J. Buell, R. Kalaba, R. Sridhar, and R. Rockwell. A computer program for digitalis dosage regimens.Math. Biosci. 9:179–193 (1970).
C. C. Peck, L. B. Sheiner, C. M. Martin, D. T. Combs, and K. L. Melmon. Computer-assisted digoxin therapy.New Engl. J. Med. 289:441–446 (1973).
F. H. Dost,Der blutspiegel Kinetic der Konzentrationsablaüfe in der Kreislaufflüssigkeit, G. Thieme Verlag, Leipzig, 1953.
J. G. Wagner, J. L. Northam, C. D. Always, and O. S. Carpenter. Blood levels of drugs at equilibrium state after multiple dosing.Nature 20:1301–1302 (1965).
E. Krüger-Thiemer. Formal theory of drug dosage regimens. I.J. Theor. Biol. 13:212–235 (1966).
E. Krüger-Thiemer. Formal theory of drug dosage regimens. II. The exact plateau effect.J. Theor. Biol. 23:169–190 (1969).
L. A. Zadeh and C. A. Desoer.Linear System Theory: The State-Space Approach, McGraw-Hill, New York, 1963.
C. M. Kunin and M. Finland. Restrictions imposed on antibiotic therapy by renal failure.Arch. Intern. Med. 104:1030–1050 (1959).
T. N. Tozer. Nomogram for modification of dosage regimens in patients with chronic renal function impairments.J. Pharmacokin. Biopharm. 2:13–28 (1974).
B. Fyro, U. Petterson, and G. Sedvall. Pharmacokinetics of lithium in manic-depressive patients.Acta Psychiat. Scand. 49:237–247 (1973).
R. W. Mason, E. G. McQueen, P. J. Keary, and N. M. James. Pharmacokinetics of lithium: Elimination half-time, renal clearance and apparent volume of distribution in schizophrenia.Clin. Pharmacokin. 3:241–246 (1978).
B. Fyro and G. Sedvall. The excretion of lithium. In F. N. Johnson (ed.),Lithium Research and Therapy, Academic Press, New York, 1975, pp. 287–312.
J. Kiefer and J. Wolfowitz. Stochastic estimation of the maximum of a regression function.Ann. Math. Stat. 23:462–466 (1952).
G. N. Saridis. Stochastic approximation methods for identification and control: A survey.IEEE Tr. Automatic Control A.C-19 6:798–809 (1974).
P. C. Baastrup and M. Schou. Lithium as a prophylactic agent: Its effect against recurrent depressions and manic-depressive psychosis.Arch. Gen. Psychiat. 16:162–172 (1967).
M. Schou. Lithium in psychiatric therapy and prophylaxis.J. Psychiat. Res. 6:67–95 (1968).
P. Deniker, D. Ginestet, and H. Loo. IntérÊt pratique de l'étude cinétique de la lithiémie au cours du nycthémère.Ann. Medico-psychol. 1:381–388 (1974).
A. Amdisen and J. Sjogren. Lithium absorption from sustained-release tablets (Duretter).Acta Pharmacol. Suec. 5:465–472 (1968).
G. Sedvall, U. Pettersson, and B. Fyro. Individual differences in serum levels of lithium in human subjects receiving fixed doses of lithium carbonate: Relation to renal lithium clearance and body weight.Pharmacol. Clin. 2:231–235 (1970).
U. Groth, W. Prellwitz, and E. Johnchen. Estimation of pharmacokinetics parameters of lithium from saliva and urine.Clin. Pharmacol. Ther. 16:490–498 (1974).
K. Thomsen and M. Schou. Renal lithium excretion in man.Amer. J. Physiol. 215:823–827 (1968).
V. Petersen, S. Hvidt, K. Thomsen, and M. Schou. Effect of prolonged thiazide treatment on renal lithium clearance.Br. Med. J. 2:143–145 (1974).
J. M. Himmelhoch, R. I. Poust, A. G. Mallinger, I. Hanin, and J. F. Neil. Adjustment of lithium dose during lithium chlorothiazide therapy.Clin. Pharmacol. Ther. 22:225–227 (1977).
R. H. Merson.An Operational Method for the Study of Integration Processes, Proceedings of Conference on Data Processing. Weapons Research Establishment, Salisbury, Australia pp. 110–1 to 110-26 (1957).
Author information
Authors and Affiliations
Additional information
This work was partly supported by grants D.G.R.S.T. No. 75.7.1267 (Adersa-Gerbios) and No. 75.7.1268 (Theraplix Laboratory).
Rights and permissions
About this article
Cite this article
Gaillot, J., Steimer, JL.J., Mallet, A.J. et al. APriori lithium dosage regimen using population characteristics of pharmacokinetic parameters. Journal of Pharmacokinetics and Biopharmaceutics 7, 579–628 (1979). https://doi.org/10.1007/BF01061210
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF01061210